On the morning of October 29th, Luo Qiang, Deputy Secretary and Mayor of Chengdu City, Sichuan Province, Cao Junjie, Deputy Mayor, and Jing Jing, Deputy Mayor, led the heads of various departments under the city and the main leaders of each district. Accompanied by Wang Daoming, Secretary of the Wenjiang District Committee, Ma Liehong, Deputy Secretary and Mayor of the District Committee, Li Yi, Deputy Secretary of the District Committee, and Lu Hongxing, Deputy District Mayor, they conducted a research on the theme of "maintaining growth and stabilizing investment" at the Mingde Zhiyuan Pharmaceutical Medical City factory.

Sun Yi, Chairman of Mingde Zhiyuan Pharmaceutical, introduced the situation of the Medical City factory to the guests. He reported on the project planning, product research and development, and production plan of Mingde Zhiyuan in Chengdu Medical City, as well as the market situation of its flagship product - ginkgolide injection, as well as the company's listing and expansion plan. Subsequently, Chairman Sun accompanied Mayor Luo and his delegation to inspect and investigate the extraction workshop of the Medical City factory.

Mayor Luo and his delegation highly praised Mingde Zhiyuan's achievements in these years and placed expectations on the enterprise. The city leaders demand that enterprises become bigger and stronger, and strive towards the "ten billion" goal.

Chairman Sun expressed gratitude to the city and district leaders for their care and support for Mingde Zhiyuan. The company will strive to build Mingde Zhiyuan's innovative drug research and production base, provide more efficient products and services to society, and contribute to the high-quality development of Chengdu's pharmaceutical and health industry.

Bai Yu Pharmaceutical executives such as Zhou Chunlei, Wei Hong, and Gao Zhiwen accompanied the research.